Pelvic organ prolapse recurrence after apical prolapse repair: does obesity matter?


Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 28 12 2020
accepted: 13 04 2021
pubmed: 4 5 2021
medline: 1 4 2022
entrez: 3 5 2021
Statut: ppublish

Résumé

We hypothesized obesity increases the risk of pelvic organ prolapse recurrence (POP-R) after primary apical prolapse repair. We conducted a retrospective cohort study of 353 women who underwent primary apical prolapse surgery from 2011 to 2016. Demographic and clinical data were abstracted from medical records. Multivariable Cox proportional hazard models were used to generate hazard ratios (HR) for association between obesity (BMI ≥ 30 kg/m Ten percent of women developed POP-R. The median follow-up time was 7 months (range 1.4, 63.9). Twenty-four percent of patients were Black and 70% were White; 37% were obese. After controlling for confounders, obese women did not have an increased risk of POP-R (aHR 1.39; 95% CI 0.67, 2.86, p = 0.38). Although only marginally statistically significant, patients who developed POP-R were more likely to be current smokers (aHR 3.48, 95% CI 1.14, 10.67; p = 0.06) or previous smokers (aHR 1.86, 95% CI 0.82, 4.24, p = 0.06) in comparison to non-smokers. Sensitivity analysis showed loss to follow-up had the potential to influence our results. Obesity was not a risk factor for POP-R in our cohort. Larger, prospective studies with longer postoperative follow-up time are needed to fully elucidate the relationship between obesity and POP-R.

Identifiants

pubmed: 33938961
doi: 10.1007/s00192-021-04806-x
pii: 10.1007/s00192-021-04806-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

275-284

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021. The International Urogynecological Association.

Références

Gutman RE, Ford DE, Quiroz LH, Shippey SH, Handa VL. Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms? Am J Obstet Gynecol. 2008;199(6):683 e681–7. https://doi.org/10.1016/j.ajog.2008.07.028 .
doi: 10.1016/j.ajog.2008.07.028
Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013;24(11):1783–90. https://doi.org/10.1007/s00192-013-2169-9 .
doi: 10.1007/s00192-013-2169-9 pubmed: 24142054
Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015;26(11):1559–73. https://doi.org/10.1007/s00192-015-2695-8 .
doi: 10.1007/s00192-015-2695-8 pubmed: 25966804 pmcid: 4611001
Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002;186(6):1160–6. https://doi.org/10.1067/mob.2002.123819 .
doi: 10.1067/mob.2002.123819 pubmed: 12066091
Whitcomb EL, Rortveit G, Brown JS, Creasman JM, Thom DH, Van Den Eeden SK, et al. Racial differences in pelvic organ prolapse. Obstet Gynecol. 2009;114(6):1271–7. https://doi.org/10.1097/AOG.0b013e3181bf9cc8 .
doi: 10.1097/AOG.0b013e3181bf9cc8 pubmed: 19935029 pmcid: 2879888
Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M, et al. Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. JAMA. 2013;309(19):2016–24. https://doi.org/10.1001/jama.2013.4919 .
doi: 10.1001/jama.2013.4919 pubmed: 23677313 pmcid: 3747840
National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults--the evidence report. Obes Res. 1998;6(Suppl 2):51S–209S.
Bradley CS, Kenton KS, Richter HE, Gao X, Zyczynski HM, Weber AM, et al. Obesity and outcomes after sacrocolpopexy. Am J Obstet Gynecol. 2008;199(6):690 e691–8. https://doi.org/10.1016/j.ajog.2008.07.030 .
doi: 10.1016/j.ajog.2008.07.030
Giri A, Hartmann KE, Hellwege JN, Velez Edwards DR, Edwards TL. Obesity and pelvic organ prolapse: a systematic review and meta-analysis of observational studies. Am J Obstet Gynecol. 2017;217(1):11–26 e13. https://doi.org/10.1016/j.ajog.2017.01.039 .
doi: 10.1016/j.ajog.2017.01.039 pubmed: 28188775
Turner L, Lavelle E, Lowder JL, Shepherd JP. The impact of obesity on intraoperative complications and prolapse recurrence after minimally invasive Sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2016;22(5):317–23. https://doi.org/10.1097/SPV.0000000000000278 .
doi: 10.1097/SPV.0000000000000278 pubmed: 27054791
Rappa C, Saccone G. Recurrence of vaginal prolapse after total vaginal hysterectomy with concurrent vaginal uterosacral ligament suspension: comparison between normal-weight and overweight women. Am J Obstet Gynecol. 2016;215(5):601 e601–4. https://doi.org/10.1016/j.ajog.2016.06.022 .
doi: 10.1016/j.ajog.2016.06.022
Pratt TS, Hudson CO, Northington GM, Greene KA. Obesity and perioperative complications in pelvic reconstructive surgery in 2013: analysis of the National Inpatient Sample. Female Pelvic Med Reconstr Surg. 2018;24(1):51–5. https://doi.org/10.1097/SPV.0000000000000454 .
doi: 10.1097/SPV.0000000000000454 pubmed: 28658002
Shah DK, Vitonis AF, Missmer SA. Association of body mass index and morbidity after abdominal, vaginal, and laparoscopic hysterectomy. Obstet Gynecol. 2015;125(3):589–98. https://doi.org/10.1097/AOG.0000000000000698 .
doi: 10.1097/AOG.0000000000000698 pubmed: 25730220
Burneikis D, Morris-Stiff G, Chalikonda S. Time attributable to obesity in surgery: a multi-specialty report on day-of-surgery resource utilization from 189,264 cases. World J Surg. 2018;42(10):3125–33. https://doi.org/10.1007/s00268-018-4599-5 .
doi: 10.1007/s00268-018-4599-5 pubmed: 29564516
Chong W, Bui AH, Menhaji K. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs. Am J Obstet Gynecol. 2020;223(2):268 e261–26. https://doi.org/10.1016/j.ajog.2020.05.020 .
doi: 10.1016/j.ajog.2020.05.020
Manodoro S, Frigerio M, Cola A, Spelzini F, Milani R. Risk factors for recurrence after hysterectomy plus native-tissue repair as primary treatment for genital prolapse. Int Urogynecol J. 2018;29(1):145–51. https://doi.org/10.1007/s00192-017-3448-7 .
doi: 10.1007/s00192-017-3448-7 pubmed: 28815283
Barber MD, Brubaker L, Burgio KL, Richter HE, Nygaard I, Weidner AC, et al. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA. 2014;311(10):1023–34. https://doi.org/10.1001/jama.2014.1719 .
doi: 10.1001/jama.2014.1719 pubmed: 24618964 pmcid: 4083455
Whiteside JL, Weber AM, Meyn LA, Walters MD. Risk factors for prolapse recurrence after vaginal repair. Am J Obstet Gynecol. 2004;191(5):1533–8. https://doi.org/10.1016/j.ajog.2004.06.109 .
doi: 10.1016/j.ajog.2004.06.109 pubmed: 15547521
Diez-Itza I, Aizpitarte I, Becerro A. Risk factors for the recurrence of pelvic organ prolapse after vaginal surgery: a review at 5 years after surgery. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(11):1317–24. https://doi.org/10.1007/s00192-007-0321-0 .
doi: 10.1007/s00192-007-0321-0 pubmed: 17333439
Friedman T, Eslick GD, Dietz HP. Risk factors for prolapse recurrence: systematic review and meta-analysis. Int Urogynecol J. 2018;29(1):13–21. https://doi.org/10.1007/s00192-017-3475-4 .
doi: 10.1007/s00192-017-3475-4 pubmed: 28921033
Aslam MF, Osmundsen B, Edwards SR, Matthews C, Gregory WT. Preoperative prolapse stage as predictor of failure of Sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2016;22(3):156–60. https://doi.org/10.1097/SPV.0000000000000233 .
doi: 10.1097/SPV.0000000000000233 pubmed: 26571435
Kawasaki A, Corey EG, Laskey RA, Weidner AC, Siddiqui NY, Wu JM. Obesity as a risk for the recurrence of anterior vaginal wall prolapse after anterior colporrhaphy. J Reprod Med. 2013;58(5–6):195–9.
pubmed: 23763002
Edenfield AL, Amundsen CL, Weidner AC, Wu JM, George A, Siddiqui NY. Vaginal prolapse recurrence after uterosacral ligament suspension in normal-weight compared with overweight and obese women. Obstet Gynecol. 2013;121(3):554–9. https://doi.org/10.1097/AOG.0b013e3182839eeb .
doi: 10.1097/AOG.0b013e3182839eeb pubmed: 23635618
Shull BL. Pelvic organ prolapse: anterior, superior, and posterior vaginal segment defects. Am J Obstet Gynecol. 1999;181(1):6–11. https://doi.org/10.1016/s0002-9378(99)70427-8 .
doi: 10.1016/s0002-9378(99)70427-8 pubmed: 10411783
Toozs-Hobson P, Boos K, Cardozo L. Management of vaginal vault prolapse. Br J Obstet Gynaecol. 1998;105(1):13–7. https://doi.org/10.1111/j.1471-0528.1998.tb09343.x .
doi: 10.1111/j.1471-0528.1998.tb09343.x pubmed: 9442155
Summers A, Winkel LA, Hussain HK, DeLancey JO. The relationship between anterior and apical compartment support. Am J Obstet Gynecol. 2006;194(5):1438–43. https://doi.org/10.1016/j.ajog.2006.01.057 .
doi: 10.1016/j.ajog.2006.01.057 pubmed: 16579933 pmcid: 1475726
Rooney K, Kenton K, Mueller ER, FitzGerald MP, Brubaker L. Advanced anterior vaginal wall prolapse is highly correlated with apical prolapse. Am J Obstet Gynecol. 2006;195(6):1837–40. https://doi.org/10.1016/j.ajog.2006.06.065 .
doi: 10.1016/j.ajog.2006.06.065 pubmed: 17132485
Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7. https://doi.org/10.1016/s0002-9378(96)70243-0 .
doi: 10.1016/s0002-9378(96)70243-0 pubmed: 8694033
Mairesse S, Chazard E, Giraudet G, Cosson M, Bartolo S. Complications and reoperation after pelvic organ prolapse, impact of hysterectomy, surgical approach and surgeon experience. Int Urogynecol J. 2020. https://doi.org/10.1007/s00192-019-04210-6 .
Park S, Baek KA. Association of General Obesity and Abdominal Obesity with the prevalence of urinary incontinence in women: cross-sectional secondary data analysis. Iran J Public Health. 2018;47(6):830–7.
pubmed: 30087868 pmcid: 6077645

Auteurs

Nina Durchfort Metcalfe (ND)

Department of Gynecology and Obstetrics, Emory University School of Medicine, Emory Gyn/Ob Clinic, 1365 Clifton Road, Bldg A, 4th Floor, Attention Daphne Blow, Atlanta, GA, 30322, USA. Nina.Metcalfe@emory.edu.

Lisa M Shandley (LM)

Department of Gynecology and Obstetrics, Emory University School of Medicine, Emory Gyn/Ob Clinic, 1365 Clifton Road, Bldg A, 4th Floor, Attention Daphne Blow, Atlanta, GA, 30322, USA.

Marisa Rogers Young (MR)

Department of Gynecology and Obstetrics, Emory University School of Medicine, Emory Gyn/Ob Clinic, 1365 Clifton Road, Bldg A, 4th Floor, Attention Daphne Blow, Atlanta, GA, 30322, USA.

Michelle Higgins (M)

Emory University School of Medicine, Atlanta, GA, USA.

Chidimma Abanulo (C)

Women's Healthcare Associates, Portland, OR, USA.

Gina M Northington (GM)

Department of Gynecology and Obstetrics, Emory University School of Medicine, Emory Gyn/Ob Clinic, 1365 Clifton Road, Bldg A, 4th Floor, Attention Daphne Blow, Atlanta, GA, 30322, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH